Browsing Tag
RMC-9805
1 post
Revolution Medicines’ Zoldonrasib demonstrates early antitumor potential in kras g12d mutant lung cancer at AACR 2025
Find out how Revolution Medicines’ new data on zoldonrasib could reshape KRAS G12D mutant lung cancer treatment strategies.